Erica Bial
Interventional Pain Medicine · Burlington, MANPI 1982663332
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (50.8%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Medtronic accounts for 60.9% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $2,539 and has fallen 82.4% since, to $446 in 2024.
Across 38 payments — averaging $119.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Abbott$612
- Curonix LLC$465
- Vertex$446
- AbbVie$108
- Medline Industries LP$54
- plus $85 from 3 others
What the payments were for
- Consulting fees$44610%
- Travel & lodging$2,29851%
- Food & beverage$1,78439%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 14 | $2,758 |
| Abbott | 9 | $612 |
| Curonix LLC | 3 | $465 |
| Vertex | 1 | $446 |
| AbbVie | 5 | $108 |
| Medline Industries LP | 2 | $54 |
| Bioventus LLC | 2 | $43 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Relievant Medsystems, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,528 in reported general payments places this provider in the 55th percentile of 22 interventional pain medicine providers in Massachusetts.
See all interventional pain medicine providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional pain medicine in Burlington
- Warren Mackie-JenkinsBoston$65K
- Mark JonesBoston$48K
- Frederic GergesBoston$21K
- David DibenedettoWaltham$17K
- Anil KumarStoneham$8K
- Omar QureshiFitchburg$7K
- Rami RustumMethuen$6K
- Janet PearlFramingham$5K
- Yuri KhibkinHolyoke$5K
- Elvis GuzmanBoston$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.